Literature DB >> 23609135

[Low molecular weight heparin decreases thrombosis risk in patients receiving chemotherapy for cancer].

S Heller1, M Krause.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609135     DOI： 10.1007/s00066-013-0352-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Routine heparin for patients with cancer? One answer, more questions.

Authors:  Elie A Akl; Holger J Schünemann
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

2.  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Authors:  Giancarlo Agnelli; Daniel J George; Ajay K Kakkar; William Fisher; Michael R Lassen; Patrick Mismetti; Patrick Mouret; Umesh Chaudhari; Francesca Lawson; Alexander G G Turpie
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 3.  Heparin as an inhibitor of cancer progression.

Authors:  Lubor Borsig
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 4.  Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Authors:  Elie A Akl; Sameer Gunukula; Maddalena Barba; Victor E D Yosuico; Frederiek F van Doormaal; Saskia Kuipers; Saskia Middeldorp; Heather O Dickinson; Andrew Bryant; Holger Schünemann
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.